COMPOSITIONS, METHOD OF BONDING, AND ASSEMBLY

Abstract
A two-part curable composition comprises a Part A and a Part B. The Part A composition includes polyuretdione having an average uretdione ring functionality of at least 1.2. Part B composition includes polythiol having an average sulfhydryl group functionality of at least 1.2. At least one of the Part A composition and the Part B composition may further comprise accelerator for addition of the polythiol to the polyuretdione. The accelerator comprises a basic salt having the formula M+Zb−x y wherein M+ is a cation having a single positive charge a, wherein a is 1, 2, or 3; Zb− is an oxide anion having a negative charge b−, wherein b is 1 or 2; and x and y are positive integers, wherein x equals y times b. Cured compositions, methods of making them and articles including them are also disclosed.
Description
TECHNICAL FIELD

The present disclosure broadly relates to compositions that include uretdione rings and methods of making and using them.


BACKGROUND

Two-part urethane adhesives, sealants and coatings are commercially available from 3M and other companies. These systems typically involve one component that is an isocyanate-terminated oligomer and a second component that is a polyol. When combined, the isocyanate reacts with the polyol to form carbamate groups. While this is established and effective chemistry, it suffers from a sensitivity to moisture and from various regulatory concerns.


It would be desirable to have alternatives to isocyanates for use in compositions such as adhesives and/or sealants that perform comparably to, or better than, the current isocyanate-based formulations in one or more applications.


SUMMARY

Advantageously, compositions and methods according to the present disclosure may exhibit properties (e.g., pot-life, open time, cure time, and/or adhesion) as adhesives and/or sealants that perform comparably to, or better than, the current isocyanate-based formulations.


In a first aspect, the present disclosure provides a two-part curable composition comprising:

    • a Part A composition comprising at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • a Part B composition comprising at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • wherein at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
        • x and y are positive integers, wherein x equals y times b.


In a second aspect, the present disclosure provides a cured composition comprising an at least partially cured reaction product of a curable composition comprising:

    • at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
        • x and y are positive integers, wherein x equals y times b.


In a third aspect, the present disclosure provides a method of bonding first and second substrates, the method comprising:

    • i) providing a curable composition comprising:
      • at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
      • at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
          • x and y are positive integers, wherein x equals y times b;
    • ii) contacting the curable composition with the first and second substrates; and
    • iii) at least partially curing the curable composition.


In a fourth aspect, the present disclosure provides an assembly comprising a composition sandwiched between first and second substrates, wherein the composition comprises a reaction product of a curable composition comprising:

    • at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
        • x and y are positive integers, wherein x equals y times b.


As used herein:


The term “basic salt” refers to a salt that forms a basic solution if dissolved in water having a pH of 7. The salt may be associated with other substances such as, e.g., water (i.e., a hydrate).


The term “sulfhydryl group” refers to the —SH group.


The term “uretdione ring” refers to a divalent C2N2O2 4-membered ring having the structure:




embedded image


Features and advantages of the present disclosure will be further understood upon consideration of the detailed description as well as the appended claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic side view of an exemplary assembly according to the present disclosure.





It should be understood that numerous other modifications and embodiments can be devised by those skilled in the art, which fall within the scope and spirit of the principles of the disclosure. The FIGURES may not be drawn to scale.


DETAILED DESCRIPTION

The present disclosure provides two-part curable compositions, cured compositions, and assemblies including them that may be useful for instance in coatings, sealants, and/or adhesives that may have good flowability and reactivity (e.g., without added solvent), acceptable cure and/or adhesion in a short amount of time, as compared to similar compositions containing isocyanates. Further, coatings, sealants, and adhesives according to at least certain embodiments of the present disclosure may be essentially free of isocyanates. This can be advantageous because isocyanates can be sensitizers upon first contact (e.g., to skin) such that subsequent contact causes inflammation. Further, coatings, sealants, and adhesives containing isocyanates exhibit more sensitivity to water than other compounds, as noted above, so minimizing an isocyanate content in a coating, sealant, or adhesive may improve reliability during curing as well as simplify storage and handling of the polymeric materials, polymerizable compositions, and two-part compositions.


Uretdiones can be formed by the 2+2 cycloaddition reaction of two isocyanate groups and has the following general formula:




embedded image


wherein each R5 is independently an organic residue. If one or both R groups contain an isocyanato group, then further reaction to prepare a uretdione-containing compound is possible; for example, as shown below:




embedded image


wherein R6 represents a divalent organic residue (preferably alkylene, arylene, or alkarylene) having from 1 to 18 carbon atoms, preferably having from 4 to 14 carbon atoms, and more preferably 4 to 8 carbon atoms, and R7 represents an organic residue free of isocyanato groups (preferably alkyl, aryl, aralkyl, or alkaryl) having from 1 to 18 carbon atoms, preferably having from 4 to 14 carbon atoms, and more preferably 4 to 8 carbon atoms. Reaction of residual isocyanate groups with mono-ols (monohydroxy alcohols) or polyols (polyhydroxy alcohols) can be used to convert the residual isocyanate groups to carbamate esters and, in the case of polyols, to uretdione-containing compounds having a uretdione functionality of 2 or more.


Isocyanate dimerization to form a uretdione is typically done using a catalyst. Examples of dimerization catalysts are: trialkylphosphines, aminophosphines and aminopyridines such as dimethylaminopyridines, and tris(dimethylamino)phosphine, as well as any other dimerization catalyst known to those skilled in the art. The result of the dimerization reaction depends, in a manner known to the skilled person, on the catalyst used, on the process conditions and on the polyisocyanates employed. In particular, it is possible for products to be formed which contain on average more than one uretdione group per molecule, the number of uretdione groups being subject to a distribution.


Polyisocyanates containing uretdione groups are well known and their preparation is described in, for example, U.S. Pat. No. 4,476,054 (Disteldorf et al.); U.S. Pat. No. 4,912,210 (Disteldorf et al.); and U.S. Pat. No. 4,929,724 (Engbert et al.), and in European Pat No. EP 0 417 603 (Bruchmann). The reaction, conducted optionally in solvent, but preferably without solvent, is terminated by addition of catalyst poisons when a desired conversion has been reached. Excess monomeric isocyanate is separated off afterward by short-path evaporation. If the catalyst is sufficiently volatile, the reaction mixture can be freed from the catalyst at the same time as monomer is separated off. In that case, there is no need to add catalyst poisons.


By including polyisocyanate compounds, uretdione-containing compounds having an average uretdione ring functionality greater than 1 can be prepared. As used herein, the term “polyisocyanate” means any organic compound that has two or more reactive isocyanate (—NCO) groups in a single molecule such as, for example, diisocyanates, triisocyanates, tetraisocyanates, and mixtures thereof. Exemplary polyisocyanates that can be used to prepare uretdione-containing compounds include: 1) aliphatic diisocyanates such as 1,2-ethylene diisocyanate; 1,4-tetramethylene diisocyanate; 1,6-hexamethylene diisocyanate; 2,2,4-trimethyl-1,6-hexamethylene diisocyanate; 2,4,4-trimethyl-1,6-hexamethylene diisocyanate; 1,9-diisocyanato-5-methylnonane; 1,8-diisocyanato-2,4-dimethyloctane; 1,12-dodecane diisocyanate; ω,ω′-diisocyanatodipropyl ether; cyclobutene 1,3-diisocyanate; cyclohexane 1,3-diisocyanate; cyclohexane 1,4-diisocyanate; 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, 1,4-diisocyanatomethyl-2,3,5,6-tetramethylcyclohexane; decahydro-8-methyl-(1,4-methanol-naphthalen)-2,5-ylenedimethylene diisocyanate; decahydro-8-methyl-(1,4-methanol-naphthalen)-3,5-ylenedimethylene diisocyanate; hexahydro-4,7-methanoindan-1,5-ylenedimethylene diisocyanate; hexahydro-4,7-methanoindan-2,5-ylenedimethylene diisocyanate; hexahydro-4,7-methanoindan-1,6-ylenedimethylene diisocyanate; hexahydro-4,7-methanoindan-2,5-ylenedimethylene diisocyanate, hexahydro-4,7-methanoindan-1,5-ylene diisocyanate; hexahydro-4,7-methanoindan-2,5-ylene diisocyanate; hexahydro-4,7-methanoindan-1,6-ylene diisocyanate; hexahydro-4,7-methanoindan-2,6-ylene diisocyanate; 2,4-hexahydrotolylene diisocyanate; 2,6-hexahydrotolylene diisocyanate; 4,4′-methylenedicyclohexyl diisocyanate; 2,2′-methylenedicyclohexyl diisocyanate; 2,4-methylenedicyclohexyl diisocyanate; 4,4′-diisocyanato-3,3′,5,5′-tetramethyldicyclohexylmethane; 4,4′-diisocyanato-2,2′,3,3,5,5′,6,6′-octamethyldicyclohexylmethane; ω,ω′-diisocyanato-1,4-diethylbenzene; 1,4-diisocyanatomethyl-2,3,5,6-tetramethylbenzene; 2-methyl-1,5-diisocyanatopentane; 2-ethyl-1,4-diisocyanatobutane; 1,10-diisocyanatodecane; 1,5-diisocyanatohexane; 1,3-diisocyanatomethylcyclohexane; 1,4-diisocyanatomethylcyclohexane; 2) aromatic diisocyanates such as 2,4-diphenylmethane diisocyanate; 4,4′-biphenylene diisocyanate; 3,3′-dimethoxy-4,4′-biphenyl diisocyanate; 3,3′-dimethyl-4, 4′-biphenyl diisocyanate; 3,3′-dimethyl-4,4′-diphenylmethane diisocyanate; xylene diisocyanate; 3-methyldiphenylmethane-4,4′-diisocyanate; 1,1-bis(4-isocyanatophenyl)-cyclohexane; m- or p-phenylene diisocyanates; chlorophenylene-2,4-diisocyanate; 1,5-diisocyanatonaphthalene; 4,4′-biphenyl diisocyanate; 3,5′-dimethyldiphenyl-4,4′-diisocyanate; diphenyl ether-4,4′-diisocyanate; and 3) combinations thereof. Triisocyanates which may be used include, for example, trimerized isocyanurate versions of the diisocyanates listed above (e.g., the isocyanurate trimer of 1,6-hexamethylene diisocyanate and related compounds such as DESMODUR N 3300 from Covestro LLC, Pittsburgh, Pa.).


Mono-functional isocyanates may also be used (e.g., to vary the uretdione-containing compound average uretdione ring functionality. Examples include vinyl isocyanate; methyl isocyanatoformate; ethyl isocyanate; isocyanato(methoxy)methane; allyl isocyanate; ethyl isocyanatoformate; isopropyl isocyanate; propyl isocyanate; trimethylsilyl isocyanate; ethyl isocyanatoacetate; butyl isocyanate; cyclopentyl isocyanate; 2-isocyanato-2-methyl-propionic acid methyl ester; ethyl 3-isocyanatopropionate; 1-isocyanato-2,2-dimethylpropane; 1-isocyanato-3-methylbutane; 3-isocyanatopentane; pentyl isocyanate; 1-ethoxy-3-isocyanatopropane; phenyl isocyanate; hexyl isocyanate; 1-adamantyl isocyanate; ethyl 4-(isocyanatomethyl)cyclohexanecarboxylate; decyl isocyanate; 2-ethyl-6-isopropylphenyl isocyanate; 4-butyl-2-methylphenyl isocyanate; 4-pentylpheny] isocyanate; undecyl isocyanate; 4-biphenylyl isocyanate; 4-phenoxyphenyl isocyanate; 2-benzylphenyl isocyanate; 4-benzylphenyl isocyanate; diphenylmethyl isocyanate; 4-(benzyloxy)phenyl isocyanate; hexadecyl isocyanate; octadecyl isocyanate; and combinations thereof. Preferred compounds include, for example, uretdione-containing compounds derived from hexamethylene diisocyanate.


The conversion of uretdione-containing compounds having a single uretdione ring to a uretdione-containing compound having at least 2 uretdione rings (i.e., a polyuretdione) may be accomplished by reaction of the free NCO groups with hydroxyl-containing compounds, which include monomers, polymers, or mixtures thereof. Examples of such compounds include, but are not limited to, polyesters, polythioethers, polyethers, polycaprolactams, polyepoxides, polyesteramides, polyurethanes or low molecular mass di-, tri- and/or tetraols as chain extenders, and if desired, mono-ols as chain terminators, for example, as described in EP 0 669 353, EP 0 669 354, DE 30 30 572, EP 0 639 598, EP 0 803 524, and U.S. Pat. No. 7,709,589. Useful uretdione-containing compounds may optionally contain isocyanurate, biuret, and/or iminooxadiazinedione groups in addition to the uretdione groups.


Uretdione-containing compounds having at least 2 uretdione groups, such as from 2 to 10 uretdione groups, and typically containing from 5 to 45% uretdione, 10 to 55% urethane, and less than 2% isocyanate groups are disclosed in U.S. Pat. No. 9,080,074 (Schaffer et al.).


One preferred uretdione-containing compound is a hexamethylene diisocyanate-based blend of materials comprising uretdione functional groups, commercially available as DESMODUR N3400 from Covestro, Pittsburgh, Pa. Additional uretdione-containing compounds are commercially available from Covestro as CRELAN EF 403, CRELAN LAS LP 6645, CRELAN VP LS 2386, and METALINK U/ISOQURE TT from Isochem Incorporated, New Albany, Ohio.


The uretdione-containing compound has an average uretdione ring functionality of at least 1.2. Accordingly, at least some components of the uretdione-containing compound contain more than one uretdione functional group. In some embodiments, the uretdione-containing compound has an average uretdione ring functionality of at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, or even at least 1.7, up to and including 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3, or more, in any combination. For example, the average uretdione ring functionality of the uretdione-containing compound may be, for example, ≥1.2, 1.2 to 3, inclusive, or 1.3 to 2.6, inclusive, of a uretdione functional group in a backbone of the polymeric material.


As mentioned hereinabove, polyols can be used to create uretdione-containing compounds having an average uretdione ring functionality of greater than 1 (e.g., at least 2 or at least 3).


One exemplary simplified general reaction scheme of a uretdione-containing compound with a polyol and a mono-ol is provided in exemplary Scheme 1 (below), wherein Z and L represent divalent organic linking groups, and R represents a monovalent organic group:




embedded image


The at least one uretdione-containing compound also typically comprises one or more carbamylene (—O—C(═O)NH—) groups per molecule. The carbamylene groups may be formed by the reaction of polyol(s) with isocyanate groups present on uretdione-containing compounds. For example, the at least one uretdione-containing compound may have an average of at least 2, at least 2.5, at least 3, at least 4, at least 5, or even at least 6 carbamylene groups up to 6, 7, 8, 9, 10, 11, 12, 13, 14, or even 15 carbamylene groups, or more, in any combination. For example, the at least one uretdione-containing compound may have an average of 2 to 15, inclusive, or 2 to 10, inclusive, of carbamylene groups.


Useful mono-ols may be primary, secondary, tertiary, linear, cyclic, and/or branched, for example. They may include, for example, C1 to C6 alkanols (e.g., methanol, ethanol, propanol, hexanol, cyclohexanol), C3 to C8 alkoxyalkanols (e.g., methoxyethanol, ethoxyethanol, propoxy propanol, or ethoxydodecanol), and polyalkyleneoxide mono-ols (e.g., mono methyl-terminated polyethylene oxide or mono ethyl-terminated polypropylene oxide). Other mono-ols can also be used, as will be understood by those of ordinary skill in the art. Some preferred mono-ols include 2-butanol, isobutanol, methanol, ethanol, propanol, pentanol, hexanol, and 2-ethylbutanol. Preferred mono-ols may have branched structures or secondary hydroxyl groups that help maintain flowability of the uretdione-containing oligomers with high solids content including, for example, 2-butanol, isobutanol, 2-ethylhexanol, and more preferably 2-butanol.


Suitable polyols may be primary, secondary, tertiary, linear, cyclic, and/or branched, for example. They may be, for example, an alkylene polyol, a polyester polyol, or a polyether polyol. Often the polyol is a diol, such as a branched diol. Exemplary suitable polyols include branched alcohols, secondary alcohols, and polyether glycols. Examples include straight or branched chain alkane polyols, such as 1,2-ethanediol, 1,3-propanediol, 1,2-propanediol, 1,4-butanediol, 1,3-butanediol, 2-methyl-1,3-propanediol, glycerol, neopentyl glycol, trimethylolethane, trimethylolpropane, di-trimethylolpropane, erythritol, pentaerythritol and di-pentaerythritol, 2-ethylhexane-1,3-diol; polyalkylene glycols, such as di-, tri- and tetraethylene glycol, and di-, tri- and tetrapropylene glycol; cyclic alkane polyols, such as cyclopentanediol, cyclohexanediol, cyclohexanetriol, cyclohexanedimethanol, hydroxypropyl-cyclohexanol and cyclohexanediethanol; aromatic polyols, such as dihydroxybenzene, benzenetriol, hydroxybenzyl alcohol and dihydroxytoluene; bisphenols, such as 4,4′-isopropylidenediphenol (bisphenol A); 4,4′-oxybisphenol, 4,4′-dihydroxybenzophenone, 4,4′-thiobisphenol, phenolphthalein, bis(4-hydroxyphenyl)methane (bisphenol F), 4,4′-(1,2-ethenediyl)bisphenol and 4,4′-sulfonylbisphenol; halogenated bisphenols, such as 4,4′-isopropylidenebis(2,6-dibromophenol), 4,4′-isopropylidenebis(2,6-dichlorophenol) and 4,4′-isopropylidenebis(2,3,5,6-tetrachlorophenol); alkoxylated bisphenols, such as alkoxylated 4,4′-isopropylidenediphenol having one or more alkoxy groups, such as ethoxy, propoxy, alpha-butoxy and beta-butoxy groups; and biscyclohexanols, which can be prepared by hydrogenating the corresponding bisphenols, such as 4,4′-isopropylidene-biscyclohexanol, 4,4′-oxybiscyclohexanol, 4,4′-thiobiscyclohexanol and bis(4-hydroxycyclohexanol)methane; higher polyalkylene glycols, such as polyethylene glycols having a number average molecular weight (Mn) of from 200 to 2000 grams per mole; hydroxyl-bearing acrylics, such as those formed from the copolymerization of (meth)acrylates and hydroxy functional (meth)acrylates, such as methyl methacrylate and hydroxyethyl methacrylate copolymers; and hydroxy functional polyesters, such as those formed from the reaction of diols, such as butanediol, and diacids or diesters, such as adipic acid or diethyl adipate; and combinations thereof. Preferred diols may have branching or secondary hydroxyl groups that help maintain flowability of the uretdione-containing oligomers with high solids content including, for example, 1,3-butanediol and neopentyl glycol.


In some preferred embodiments, the polyol has from 2 to 50 carbon atoms, preferably from 2 to 18 carbon atoms, and more preferably 2 to 8 carbon atoms. In some preferred embodiments, the polyol is polymeric and has from 10 to 200 carbon atoms. Examples include hydroxyl-terminated polyetherdiols and hydroxyl-terminated polyester diols.


Useful commercially available polyols include, for example, those from Covestro LLC, Pittsburgh, Pa., as DESMOPHEN 1652, DESMOPHEN 800, DESMOPHEN 850, DESMOPHEN C 1100, DESMOPHEN C 1200, DESMOPHEN C 2100, DESMOPHEN C 2200, and DESMOPHEN C XP 2716.


Useful thiol-containing compounds are organic compounds having at least 1, at least 2, at least 3, at least 4, or even at least 6 thiol groups. Suitable thiol-containing compounds having a single —SH group may include, for example, ethanethiol, 1-propanethiol, 1-butanethiol, 6-mercapto-1-hexanol, 3-mercapto-1-hexanol, 4-mercapto-4-methylpentan-2-ol, 3-mercaptobutyl acetate, 8-mercapto-1-octanol, 9-mercapto-1-nonanol, 1-nonanethiol, 1-decanethiol, and 3-mercaptohexyl hexanoate.


Combinations of thiol-containing compounds may be used. The average thiol functionality of the at least one thiol-containing compound is at least 2. Preferably, the average thiol functionality of the at least one thiol-containing compound is from 2 to 7, more preferably 2 to 5, more preferably 2.5 to 4.5, and more preferably 3.7 to 4.3. Preferred combinations include miscible mixtures, although this is not a requirement.


Many thiol-containing compounds having one thiol group are useful in practice of the method according to the present disclosure.


Many thiol-containing compounds having at least two thiol groups (i.e., polythiols) are useful in practice of the method according to the present disclosure. In some embodiments, polythiol may be an alkylene, arylene, alkylarylene, arylalkylene, or alkylenearylalkylene having at least two mercaptan groups, wherein any of the alkylene, alkylarylene, arylalkylene, or alkylenearylalkylene are optionally interrupted by one or more oxa (i.e., —O—), thia (i.e., —S—), or imino groups (i.e., —NR3— wherein R3 is a hydrocarbyl group or H), and optionally substituted by alkoxy or hydroxyl.


Examples of useful dithiols include 1,2-ethanedithiol, 1,2-propanedithiol, 1,3-propanedithiol, 1,3-butanedithiol, 1,4-butanedithiol, 2,3-butanedithiol, 1,3-pentanedithiol, 1,5-pentanedithiol, 1,6-hexanedithiol, 1,3-dimercapto-3-methylbutane, dipentenedimercaptan, ethylcyclohexyldithiol (ECHDT), dimercaptodiethyl sulfide, methyl-substituted dimercaptodiethyl sulfide, dimethyl-substituted dimercaptodiethyl sulfide, dimercaptodioxaoctane, 1,5-dimercapto-3-oxapentane,benzene-1,2-dithiol, benzene-1,3-dithiol, benzene-1,4-dithiol, and tolylene-2,4-dithiol. Examples of polythiols having more than two mercaptan groups include propane-1,2,3-trithiol; 1,2-bis[(2-mercaptoethyl)thio]-3-mercaptopropane; tetrakis(7-mercapto-2,5-dithiaheptyl)methane; and trithiocyanuric acid.


Also useful are polythiols formed from the esterification of polyols with thiol-containing carboxylic acids or their derivatives. Examples of polythiols formed from the esterification of polyols with thiol-containing carboxylic acids or their derivatives include those made from the esterification reaction between thioglycolic acid or 3-mercaptopropionic acid and several polyols to form the mercaptoacetates or mercaptopropionates, respectively.


Examples of polythiol compounds preferred because of relatively low odor level include, but are not limited to, esters of thioglycolic acid, α-mercaptopropionic acid, and β-mercaptopropionic acid with polyhydroxy compounds (polyols) such as diols (e.g., glycols), triols, tetraols, pentaols, and hexaols. Specific examples of such polythiols include, but are not limited to, ethylene glycol bis(thioglycolate), ethylene glycol bis(β-mercaptopropionate), trimethylolpropane tris(thioglycolate), trimethylolpropane tris(β-mercaptopropionate) and ethoxylated versions, pentaerythritol tetrakis(thioglycolate), pentaerythritol tetrakis(β-mercaptopropionate), and tris(hydroxyethyl)isocyanurate tris(β-mercaptopropionate). However, in those applications where concerns about possible hydrolysis of the ester exists, these polyols are typically less desirable.


Suitable polythiols also include those commercially available as THIOCURE PETMP (pentaerythritol tetra(3-mercaptopropionate)), TMPMP (trimethylolpropane tri(3-mercaptopropionate)), ETTMP (ethoxylated trimethylolpropane tri(3-mercaptopropionate) such as ETTMP 1300 and ETTMP 700), GDMP glycol di(3-mercaptopropionate), TMPMA (trimethylolpropane tri(mercaptoacetate)), TEMPIC (tris[2-(3-mercaptopropionyloxy)ethyl] isocyanurate), and PPGMP (propylene glycol 3-mercaptopropionate) from Bruno Bock Chemische Fabrik GmbH & Co. KG. A specific example of a polymeric polythiol is polypropylene-ether glycol bis(β-mercaptopropionate), which is prepared from polypropylene-ether glycol (e.g., PLURACOL P201, Wyandotte Chemical Corp.) and (3-mercaptopropionic acid by esterification.


Suitable polythiols also include those prepared from esterification of polyols with thiol-containing carboxylic acids or their derivatives, those prepared from a ring-opening reaction of epoxides with H2S (or its equivalent), those prepared from the addition of H2S (or its equivalent) across carbon-carbon double bonds, polysulfides, polythioethers, and polydiorganosiloxanes. Specifically, these include the 3-mercaptopropionates (also referred to as β-mercaptopropionates) of ethylene glycol and trimethylolpropane (the former from Chemische Fabrik GmbH & Co. KG, the latter from Sigma-Aldrich); POLYMERCAPTAN 805C (mercaptanized castor oil); POLYMERCAPTAN 407 (mercaptohydroxy soybean oil) from Chevron Phillips Chemical Co. LLP, and CAPCURE, specifically CAPCURE 3-800 (a polyoxyalkylenetriol with mercapto end groups of the structure R3[O(C3H6O)nCH2CH(OH)CH2SH]3 wherein R3 represents an aliphatic hydrocarbon group having 1-12 carbon atoms and n is an integer from 1 to 25), from Gabriel Performance Products, Ashtabula, Ohio, and GPM-800, which is equivalent to CAPCURE 3-800, also from Gabriel Performance Products.


Examples of oligomeric or polymeric polythioethers useful for practicing the present disclosure are described, for example, in U.S. Pat. No. 4,366,307 (Singh et al.), U.S. Pat. No. 4,609,762 (Morris et al.), U.S. Pat. No. 5,225,472 (Cameron et al.), U.S. Pat. No. 5,912,319 (Zook et al.), U.S. Pat. No. 5,959,071 (DeMoss et al.), U.S. Pat. No. 6,172,179 (Zook et al.), and U.S. Pat. No. 6,509,418 (Zook et al.).


In some embodiments, the polythiol in the method according to the present disclosure is oligomeric or polymeric. Examples of useful oligomeric or polymeric polythiols include polythioethers and polysulfides. Polythioethers include thioether linkages (i.e., —S—) in their backbone structures. Polysulfides include disulfide linkages (i.e., —S—S—) in their backbone structures.


Polythioethers can be prepared, for example, by reacting dithiols with dienes, diynes, divinyl ethers, diallyl ethers, ene-ynes, alkynes, or combinations of these under free-radical conditions. Useful dithiols include any of the dithiols listed above. Examples of suitable divinyl ethers include divinyl ether, ethylene glycol divinyl ether, butanediol divinyl ether, hexanediol divinyl ether, diethylene glycol divinyl ether, triethylene glycol divinyl ether, tetraethylene glycol divinyl ether, cyclohexanedimethanol divinyl ether, polytetrahydrofuryl divinyl ether, and combinations of any of these. Useful divinyl ethers of formula CH2═CHO(R8O)mCH═CH2, in which m is a number from 0 to 10, R8 is C2 to C6 branched alkylene. Such compounds can be prepared by reacting a polyhydroxy compound with acetylene. Examples of compounds of this type include compounds in which R8 is an alkyl-substituted methylene group such as —CH(CH3)— (e.g., those obtained from BASF, Florham Park, N.J., as “PLURIOL”, for which R8 is ethylene and m is 3.8) or an alkyl-substituted ethylene (e.g., —CH2CH(CH3)— such as those obtained from International Specialty Products of Wayne, N.J., as “DPE” (e.g., DPE-2 and DPE-3). Examples of other suitable dienes, diynes, and diallyl ethers include 4-vinyl-1-cyclohexene, 1,5-cyclooctadiene, 1,6-heptadiyne, 1,7-octadiyne, and diallyl phthalate. Small amounts of trifunctional compounds (e.g., triallyl-1,3,5-triazine-2,4,6-trione, 2,4,6-triallyloxy-1,3,5-triazine) may also be useful in the preparation of oligomers.


Examples of oligomeric or polymeric polythioethers useful for practicing the present disclosure are described, for example, in U.S. Pat. No. 4,366,307 (Singh et al.), U.S. Pat. No. 4,609,762 (Morris et al.), U.S. Pat. No. 5,225,472 (Cameron et al.), U.S. Pat. No. 5,912,319 (Zook et al.), U.S. Pat. No. 5,959,071 (DeMoss et al.), U.S. Pat. No. 6,172,179 (Zook et al.), and U.S. Pat. No. 6,509,418 (Zook et al.). In some embodiments, the polythioether is represented by formula HSR9[S(CH2)2O[R10O]m(CH2)2SR9]nSH, wherein each R9 and R10 is independently a C2-6 alkylene, wherein alkylene may be straight-chain or branched, C6-8 cycloalkylene, C6-10 alkylcycloalkylene, —[(CH2)pX]q(CH2)r in which at least one —CH2— is optionally substituted with a methyl group, X is one selected from the group consisting of O, S and —NR11—, where R11 denotes hydrogen or methyl, m is a number from 0 to 10, n is a number from 1 to 60, p is an integer from 2 to 6, q is an integer from 1 to 5, and r is an integer from 2 to 10. Polythioethers with more than two mercaptan groups may also be useful.


Polythioethers can also be prepared, for example, by reacting dithiols with diepoxides, which may be carried out by stirring at room temperature, optionally in the presence of a tertiary amine catalyst (e.g., 1,4-diazabicyclo[2.2.2]octane (DABCO)). Useful dithiols include any of those described above. Useful epoxides can be any of those having two epoxide groups. In some embodiments, the diepoxide is a bisphenol diglycidyl ether, wherein the bisphenol (i.e., —OC6H5CH2C6H5O—) may be unsubstituted (e.g., bisphenol F), or either of the phenyl rings or the methylene group may be substituted by halogen (e.g., fluoro, chloro, bromo, iodo), methyl, trifluoromethyl, or hydroxymethyl. Polythioethers prepared from dithiols and diepoxides have pendent hydroxyl groups and can have structural repeating units represented by formula —SR9SCH2CH(OH)CH2OC6H5CH2C6H5OCH2CH(OH)CH2SR9S—, wherein R9 is as defined above, and the bisphenol (i.e., —OC6H5CH2C6H5O—) may be unsubstituted (e.g., bisphenol F), or either of the phenyl rings or the methylene group may be substituted by halogen (e.g., fluoro, chloro, bromo, iodo), methyl, trifluoromethyl, or hydroxymethyl. Mercaptan terminated polythioethers of this type can also be reacted with any of the dienes, diynes, divinyl ethers, and diallyl ethers.


Other useful polythiols can be formed from the addition of hydrogen sulfide (H2S) (or its equivalent) across carbon-carbon double bonds. For example, dipentene and triglycerides which have been reacted with H2S (or its equivalent). Specific examples include dipentene dimercaptan and those polythiols available as POLYMERCAPTAN 358 (mercaptanized soybean oil) and POLYMERCAPTAN 805C (mercaptanized castor oil) from Chevron Phillips Chemical Co. LLP. At least for some applications, the preferred polythiols are POLYMERCAPTAN 358 and 805C since they are produced from largely renewable materials, i.e., the triglycerides, soybean oil and castor oil, and have relatively low odor in comparison to many thiols. Useful triglycerides have at least 2 sites of unsaturation, i.e., carbon-carbon double bonds, per molecule on average, and sufficient sites are converted to result in at least 2 thiols per molecule on average. In the case of soybean oil, this requires a conversion of approximately 42 percent or greater of the carbon-carbon double bonds, and in the case of castor oil this requires a conversion of approximately 66 percent or greater of the carbon-carbon double bonds. Typically, higher conversion is preferred, and POLYMERCAPTAN 358 and 805C can be obtained with conversions greater than approximately 60 percent and 95 percent, respectively. Useful polythiols of this type also include those derived from the reaction of H2S (or its equivalent) with the glycidyl ethers of bisphenol A epoxy resins, bisphenol F epoxy resins, and novolak epoxy resins. A preferred polythiol of this type is QX11, derived from bisphenol A epoxy resin, from Japan Epoxy Resins (JER) as EPOMATE. Other polythiols suitable include those available as EPOMATE QX10 and EPOMATE QX20 from JER.


Still other useful polythiols are polysulfides that contain thiol groups such as those available as THIOKOL LP-2, LP-3, LP-12, LP-31, LP-32, LP-33, LP-977, and LP-980 from Toray Fine Chemicals Co., Ltd., and polythioether oligomers and polymers such as those described in PCT Publ. No. WO 2016130673 A1 (DeMoss et al.).


The at least one accelerator comprises a basic salt having the formula





M+xZb−y

    • wherein
      • M+ is a cation having a single positive charge;
      • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
      • x and y are positive integers, wherein x equals y times b.


Exemplary cations M+ include alkali metal (e.g., lithium, sodium, potassium, or cesium) cations quaternary ammonium (e.g., tetrabutylammonium, tetramethylammonium, or triethylphenylammonium) cations, quaternary phosphonium (e.g., tetrabutylphosphonium or trimethylphenylphosphonium) cations. If M+ comprises an organic onium compound, it preferably contains less than or equal to 48 carbon atoms, more preferably less than or equal to 24 carbon atoms, and more preferably less than or equal to 16 carbon atoms.


Exemplary Zb− oxide anions include hydroxide (b=1), alkoxide (e.g., methoxide, ethoxide, isopropoxide, t-butoxide) anions (b=1), carboxylate (e.g., formate, acetate, propionate, butyrate) anions (b=1), bicarbonate (b=1), carbonate (b=2), oxalate (b=2), oxide (i.e., O) anions (b=2). As used herein, the term “oxide anion” refers to an oxygen-localized anion that forms a basic solution if added to deionized water in sufficient quantity.


In some preferred embodiments, the at least accelerator is free of substituted or unsubstituted imidazole, amidine, and/or triazole groups.


Curable and cured compositions according to the present disclosure may further comprise one or more additives such as, for example, plasticizers, non-reactive diluents, fillers, flame retardants, and colorants.


A plasticizer is often added to the curable composition to make the polymeric material more flexible, softer, and more workable (e.g., easier to process). More specifically, the mixture resulting from the addition of the plasticizer to the polymeric material typically has a lower glass transition temperature compared to the polymeric material alone. The glass transition temperature of the curable composition can be lowered, for example, by at least 30° C., at least 40° C., at least 50° C., at least 60° C., or even at least 70° C. by the addition of one or more plasticizers. The temperature change (i.e., decrease) tends to correlate with the amount of plasticizer added to the polymeric material. It is the lowering of the glass transition temperature that usually leads to the increased flexibility, increased elongation, and increased workability. Some example plasticizers include various phthalate esters such as diethyl phthalate, diisobutyl phthalate, dibutyl phthalate, diisoheptyl phthalate, dioctyl phthalate, diisooctyl phthalate, dinonyl phthalate, diisononyl phthalate, diisodecyl phthalate, and benzylbutyl phthalate; various adipate esters such as di-2-ethylhexyl adipate, dioctyl adipate, diisononyl adipate, and diisodecyl adipate; various phosphate esters such as tri-2-ethylhexyl phosphate, 2-ethylhexyl diphenyl phosphate, trioctyl phosphate, and tricresyl phosphate; various trimellitate esters such as tris-2-ethylhexyl trimellitate and trioctyl trimellitate; various sebacate and azelate esters; and various sulfonate esters. Other example plasticizers include polyester plasticizers that can be formed by a condensation reaction of propanediols or butanediols with adipic acid.


In certain embodiments, the curable composition is used in an application where it is disposed between two substrates, wherein solvent removal (e.g., evaporation) is restricted, especially when one or more of the substrates comprises a moisture impermeable material (e.g., steel or glass). In such cases, the polymeric material comprises a solids content of 90% or greater, 92% or greater, 94% or greater, 95% or greater, 96% or greater, 98% or greater, or 99% or greater. Likewise, in such embodiments where solvent removal is restricted, the first part (Part A), the second part (Part B), or both parts of a two-part curable composition according to the present disclosure preferably comprises a solids content of at least 90%, at least 92%, at least 94%, at least 95%, at least 96%, at least 98%, or even at least 99%. Components that are considered “solids” include, for instance and without limitation, polymers, oligomers, monomers, hydroxyl-containing compounds, and additives such as plasticizers, catalysts, non-reactive diluents, and fillers. Typically, only solvents (e.g., water, organic solvent(s), and combinations thereof) do not fall within the definition of solids.


For convenient handleability, the curable composition typically comprises a dynamic viscosity of 10 Poise (P) or greater as determined using a Brookfield viscometer, 50 P or greater, 100 P or greater, 150 P or greater, 250 P or greater, 500 P or greater, 1,000 P or greater, 1,500 P or greater, 2,000 P or greater, 2,500 P or greater, or even 3,000 P or greater; and 10,000 P or less, 9,000 P or less, 8,000 P or less, 7,000 P or less, 6,000 P or less, 5,000 P or less, or even 4,000 P or less, as determined using a Brookfield viscometer. Stated another way, the polymeric material may exhibit a dynamic viscosity of 10 Poise (P) to 10,000 P, inclusive, or 10 P to 4,000 P, inclusive, as determined using a Brookfield viscometer. Conditions for the dynamic viscosity test include use of a LV4 spindle at a speed of 0.3 or 0.6 revolutions per minute (RPM) at 24° C.


Depending on the particular application, an amount of each of the Part A and the Part B obtained will vary; in certain embodiments, an excess of one or both of the Part A and the Part B is obtained and hence only a portion of one or both of the Part A and the Part B, respectively, will be combined to form a mixture. In other embodiments, however, a suitable amount of each of the Part A and the Part B for adhering the first and second substrates together is obtained and essentially all of the Part A and the part B is combined to form the mixture. In certain embodiments, combining a (e.g., predetermined) amount of the Part A with a (e.g., predetermined) amount of the Part B is performed separately from the first and second substrates, while in other embodiments the combining is performed (e.g., directly) on the first major surface of a substrate.


Curable compositions according to the present disclosure may be used to bond two substrates together to form a bonded assembly. In general, Part A and Part B are combined to form a curing composition, which is then applied to one or both substrate, and pressed together to form an adhesive bond after curing. If used as a sealant pressing may not be performed. After curing a bonded assembly results.


The mixture is typically applied to (e.g., disposed on) the surface of one or both substrate using conventional techniques such as, for example, dispensing, bar coating, roll coating, curtain coating, rotogravure coating, knife coating, spray coating, spin coating, or dip coating techniques. Coating techniques such as bar coating, roll coating, and knife coating are often used to control the thickness of a layer of the mixture. In certain embodiments, the disposing comprises spreading the mixture on the first major surface of the first substrate, for instance when the mixture is dispensed (e.g., with a mixing nozzle) on the surface of the substrate such that the mixture does not cover the entirety of a desired area.


Referring to FIG. 1, a bonded assembly 100 is illustrated. The bonded assembly 100 comprises at least partially cured composition 120 (e.g., an adhesive) sandwiched between first and second substrates (130, 140).


Advantageously, the two-part curable compositions when the Part A and Part B are combined are capable of adhering two substrates together. Following cure, the adhesive preferably exhibits a minimum overlap shear on aluminum of 0.3 megaPascals (MPa), 1 MPa, 5 MPa, 10 MPa, or 25 MPa.


Curable compositions according to the present disclosure are typically supplied as two-part curable compositions (i.e., a Part A and a Part B in separate containers) that are stable separately but react to cure when mixed together, although this is not a requirement.


SELECT EMBODIMENTS OF THE PRESENT DISCLOSURE

In a first embodiment, the present disclosure provides a two-part curable composition comprising:

    • a Part A composition comprising at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • a Part B composition comprising at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • wherein at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
        • x and y are positive integers, wherein x equals y times b.


In a second embodiment, the present disclosure provides a two-part curable composition according to the first embodiment, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.


In a third embodiment, the present disclosure provides a two-part curable composition according to the first or second embodiment, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.


In a fourth embodiment, the present disclosure provides a two-part curable composition according to any one of the first to third embodiments, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01.


In a fifth embodiment, the present disclosure provides a two-part curable composition according to any one of the first to fourth embodiments, wherein the at least one polythiol has an average sulfhydryl group functionality of at least 2.5.


In a sixth embodiment, the present disclosure provides a two-part curable composition according to any the fifth embodiment, wherein the at least one polythiol has an average sulfhydryl group functionality of less than or equal to 5.


In a seventh, the present disclosure provides a two-part curable composition according to any one of the first to sixth embodiments, wherein the Part A composition and the Part B composition are flowable at 20° C.


In an eighth embodiment, the present disclosure provides a cured composition comprising an at least partially cured reaction product of a curable composition comprising:

    • at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and


x and y are positive integers, wherein x equals y times b. In a ninth embodiment, the present disclosure provides a cured composition according to the eighth embodiment, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.


In a tenth embodiment, the present disclosure provides a cured composition according to the eighth or ninth embodiment, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.


In an eleventh embodiment, the present disclosure provides a cured composition according to any one of the eighth to tenth embodiments, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01.


In a twelfth embodiment, the present disclosure provides a cured composition according to any one of the eighth to eleventh embodiments, wherein the at least one polythiol has an average sulfhydryl group functionality of at least 2.5.


In a thirteenth embodiment, the present disclosure provides a cured composition according to the twelfth embodiment, wherein the at least one polythiol has an average sulfhydryl group functionality of less than or equal to 5.


In a fourteenth embodiment, the present disclosure provides a cured composition according to any one of the eighth to thirteenth embodiments, wherein the curable composition is flowable at 20° C. before curing.


In a fifteenth embodiment, the present disclosure provides a method of bonding first and second substrates, the method comprising:


i) providing a curable composition comprising:

    • at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

    • wherein
      • M+ is a cation having a single positive charge;
      • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
        • x and y are positive integers, wherein x equals y times b;


ii) contacting the curable composition with the first and second substrates; and


iii) at least partially curing the curable composition.


In a sixteenth embodiment, the present disclosure provides a method according to the fifteenth embodiment, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.


In a seventeenth embodiment, the present disclosure provides a method according to the fifteenth or sixteenth embodiment, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.


In an eighteenth embodiment, the present disclosure provides a method according to any one of the fifteenth to seventeenth embodiments, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01.


In a nineteenth embodiment, the present disclosure provides a method according to any one of the fifteenth to eighteenth embodiments, wherein the at least one polythiol has an average sulfhydryl group functionality of at least 2.5.


In a twentieth embodiment, the present disclosure provides a method according to any one of the fifteenth to nineteenth embodiments, wherein the at least one polythiol has an average sulfhydryl group functionality of less than or equal to 5.


In a twenty-first embodiment, the present disclosure provides a method according to the twentieth embodiment, wherein the curable composition is flowable at 20° C. before curing.


In a twenty-second embodiment, the present disclosure provides an assembly comprising a composition sandwiched between first and second substrates, wherein the composition comprises a reaction product of a curable composition comprising:

    • at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;
    • at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; and
    • at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula





M+xZb−y

      • wherein
        • M+ is a cation having a single positive charge;
        • Zb− is an oxide anion having a negative charge b, wherein b is 1 or 2; and
        • x and y are positive integers, wherein x equals y times b.


In a twenty-third embodiment, the present disclosure provides an assembly according to the twenty-second embodiment, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.


In a twenty-fourth embodiment, the present disclosure provides an assembly according to the twenty-second or twenty-third embodiment, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.


In a twenty-fifth embodiment, the present disclosure provides an assembly according to any one of the twenty-second to twenty-fourth embodiments, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01.


In a twenty-sixth embodiment, the present disclosure provides an assembly according to any one of the twenty-second to twenty-fifth embodiments, wherein the at least one polythiol has an average sulfhydryl group functionality of at least 2.5.


In a twenty-seventh embodiment, the present disclosure provides an assembly according to the twenty-sixth embodiment, wherein the at least one polythiol has an average sulfhydryl group functionality of less than or equal to 5.


In a twenty-eighth embodiment, the present disclosure provides an assembly according to any one of the twenty-second to twenty-seventh embodiments, wherein the curable composition is flowable at 20° C. before curing.


Objects and advantages of this disclosure are further illustrated by the following non-limiting examples, but the particular materials and amounts thereof recited in these examples, as well as other conditions and details, should not be construed to unduly limit this disclosure.


EXAMPLES

Unless otherwise noted, all parts, percentages, ratios, etc. in the Examples and the rest of the specification are by weight. Unless otherwise indicated, all other reagents were obtained, or are available from fine chemical vendors such as Sigma-Aldrich Company, St. Louis, Mo., or may be synthesized by known methods. Table 1 (below) lists materials used in the examples and their sources. In the Tables, “NA” means not applicable. In the examples: EX—designates working examples, CEX—designates comparative examples, and PEX—designates preparative examples.











TABLE 1





DESIGNATION
DESCRIPTION
SOURCE







DN3400
HDI-based oligomer with uretdione
Covestro,



functional groups obtained under the trade
Leverkusen,



designation DESMODUR N3400
Germany


2-ethylhexanol
2-ethylhexanol
Alfa Aesar,




Haverhill,




Massachusetts


2-butanol
2-butanol
Alfa Aesar


2, 2-dimethyl-1, 3-propanediol
2, 2-dimethyl-1, 3-propanediol
Alfa Aesar


BiND
bismuth neodecanoate
Gelest,




Morrisville,




Pennsylvania


ZnND
zinc neodecanoate
Alfa Aesar


DBTDL
dibutyltin dilaurate
Alfa Aesar


TsoH*H2O
p-toluenesulfonic acid monohydrate
Alfa Aesar


TBA
Acetate tetrabutylammonium acetate
Alfa Aesar


KOtBu
potassium t-butoxide
Alfa Aesar


PETMP
pentaerythritol tetrakis
TCI America,



(3-mercaptopropionate)
Portland, Oregon



(tetrafunctional thiol curative)



DMDO
3, 6-dioxa-1, 8-octane-dithiol
TCI America



(difunctional thiol curative)



TMPTMP
trimethylolpropane tri
TCI America



(3-mercaptopropionate)




(trifunctional thiol curative)



KOH
potassium hydroxide
VWR,




Radnor,




Pennsylvania


zirconium 2, 4-pentadionate
zirconium 2, 4-pentadionate
Johnson Matthey,




Royston, United




Kingdom


TMA OH (25% aq)
25% tetramethylammonium hydroxide
Alfa Aesar



solution in H2O



KOAc
potassium acetate
Alfa Aesar


LiOH
lithium hydroxide
Alfa Aesar


K2CO3
potassium carbonate
VWR


TMAOH * 5H2O
tetramethylammonium hydroxide
Alfa Aesar



pentahydrate



NaOH
sodium hydroxide
EMD Millipore,




Billerica,




Massachusetts


Cs2CO3
cesium carbonate
Alfa Aesar


CsOAc
cesium acetate
Alfa Aesar


sodium acetate trihydrate
sodium acetate trihydrate
Alfa Aesar


THF1000
TERATHANE 1000; poly
Invista,



(tetramethyleneether) glycol with a
Wichita, Kansas



molecular weight of 1000 g/mol



1, 5-diazabycyclo[4.3.0]non-5-ene
1, 5-diazabycyclo[4.3.0]non-5-ene
Alfa Aesar


7-methy1-1, 5, 7-triazabicyclo
7-methy1-1, 5, 7-triazabicyclo
TCI America


[4.4.0]dec-5ene
[4.4.0]dec-5ene



1, 5, 7-triazabicyclo[4.4.0]dec-5-ene
1, 5, 7-triazabicyclo[4.4.0]dec-5-ene
Sigma-Aldrich,


(predissolved in thiol)
(predissolved in thiol)
St. Louis,




Missouri


PDBU
tertiary amine catalyst obtained as
Evonik Industries



POLYCAT DBU (1, 8-diazabicyclo
AG



[5.4.0]-undec-7-ene)
Essen, Germany


DBU
1, 8-diazabicyclo[5.4.0]undec-7-ene
Alfa Aesar









Test Methods
Overlap Shear Test Method

The performance of adhesives derived from uretdione oligomers was determined using overlap shear tests. Aluminum coupons (25 mm×102 mm×1.6 mm) were sanded with 220 grit sandpaper and wiped with isopropanol and dried. The uretdione oligomer and the thiol curative were each added to a plastic cup and mixed for 45 seconds to 90 seconds using a speed mixer (DAC 150 FV SpeedMixer from FlackTek, Landrum, S.C.). Catalyst was then added, and the mixture was mixed for 15 to 30 seconds using a combination of hand mixing with a wood applicator stick and the speed mixer. The mixture was then applied to a 25 mm×13 mm area on one end of the aluminum coupon, and two pieces of stainless steel wire (0.25 mm diameter) were placed in the resin to act as bondline spacers. One end of a second aluminum coupon was then pressed into to the mixture to produce an overlap of approximately 13 mm. A binder clip was placed on the sample, and it was allowed to cure for at least 18 hours. The samples were tested to failure in shear mode at a rate of 2.54 mm/minute using a tensile load frame with self-tightening grips (MTS Systems, Eden Prairie, Minn.). After failure, the length of the overlap area was measured. The overlap shear value was then calculated by dividing the peak load by the overlap area.


Gel Point Determination

The pot life of uretdione oligomers was determined by monitoring the time required to reach a gel. The uretdione oligomer and the thiol curative were each added to a plastic cup and mixed for 30 seconds using a DAC 150 FV SpeedMixer at 3000 revolutions per minute (RPM). The mixture was mixed by hand for 10 seconds and then mixed again for 30 seconds using a speed mixer at 3000 RPM. Catalyst was then added and the mixture was mixed for 30 seconds using a speed mixer at 3000 RPM. The mixture was hand-mixed until the material could not be drawn without breaking, which was determined to be the gel point. Time was calculated from the addition of catalyst until the moment gelation occurred.


FTIR Characterization

The infrared (IR) spectra of the oligomer samples and the cured adhesives were obtained using an infrared Fourier transform spectrometer (Nicolet 6700 FT-IR Spectrometer, Thermo Scientific, Madison, Wis.) equipped with a Smart iTR Diamond Attenuated Total Reflectance (ATR) accessory. For all the oligomers the isocyanate peak at 2260 cm−1 was not present in the infrared spectrum, indicating that the isocyanate had reacted completely with the alcohols during the preparation of the oligomers. For all the oligomers, a strong uretdione signal at 1760 cm−1 was observed. For all the cured adhesives, the uretdione signal at 1760 cm1 had nearly disappeared, indicating reaction of the uretdione group during the cure of the adhesives.


NMR Analysis of DN3400

DN3400 was dissolved in deuterated dimethyl sulfoxide (DMSO) solvent. The 1H proton spectrum was taken with a 500 MHz NMR (AVANCE III 500 MHz spectrometer equipped with a broadband cryoprobe from Bruker, Billerica, Mass.). The resulting spectrum had 5 major signals. Signals at 1.31 parts per million (ppm) and 1.55 ppm were attributed to methylene groups at the 3 and 4 positions and the 2 and 5 positions of the HDI derivatives, respectively. A signal at 3.17 ppm was attributed to methylene protons adjacent to a uretdione group. A signal at 3.34 ppm was attributed to methylene protons adjacent to an isocyanate group. A signal at 3.74 ppm was attributed to methylene protons adjacent to an isocyanurate group. The integrations of these three methylene signals were 1.35, 1.79, and 0.49, respectively. The published values for DN3400 are an equivalent weight of isocyanate of 193 g/equivalent and 22 weight percent isocyanate. The ratio of the integration of the signal at 3.17 ppm over the integration of the signal at 3.34 ppm is 0.75, which corresponds to 16 wt. % uretdione. The ratio of the integration of the signal at 3.74 ppm over the integration of the signal at 3.34 ppm is 0.27, which corresponds to 3 wt. % isocyanurate. The functionality of DN3400 is published as 2.5 (in “Raw Materials for Automotive Refinish Systems” from Bayer Materials Science, 2005), so the average molecular weight of the molecule in DN3400 is 193 grams/equivalent x 2.5 equivalents/mole=482 grams/mol. For every 2.5 isocyanate methylene groups, there are 0.75*2.5=1.875 uretdione methylene groups. There are two methylene groups per uretdione group, so there are about 0.94 uretdione groups per molecule of DN3400.


Calculation of Uretdione Functionality in Oligomers

A modified Carothers equation relates degree of polymerization (DP) to the average functionality (fav) and conversion (p) in a step growth polymerization [Carothers, Wallace, “Polymers and Polyfunctionality”, Transactions of the Faraday Society, 1936, vol. 32, pp 39-49]:






DP=2/(2−pfav)


This equation can be used to calculate the average degree of polymerization of each oligomer. Based on the degree of polymerization, the average number of uretdione groups in the oligomer (fUD) can be calculated by:






f(UD)=DP*(DN3400 molecules)*(uretdione groups per DN3400 molecule)/(total molecules)


where the values for “DN3400 molecules” and the “total molecules” correspond to the respective moles of molecules used to make the oligomer, and the value for “uretdione groups per DN3400 molecule” is 0.94, as calculated based on the NMR data (above).


General Oligomer Preparation

Bismuth neodecanoate, DN3400 (HDI-based uretdione-containing material obtained as DESMODUR N 3400 from Covestro), the chain extender, and the capping group were added to a glass jar according to Table 2. The amounts of alcohol that were added correspond to the equivalent values in Tables 2 to 3 (relative to the equivalents of isocyanate). The mixture was stirred magnetically at 700 RPM. Initially the mixture was hazy, and after about one minute, the mixture became clear and slightly warm. The mixture then continued to exotherm noticeably. Stirring was continued for a total of 5 minutes, and the oligomer was then allowed to cool to room temperature.


The calculated uretdione functionality of each formulation are summarized in Table 2.


The mixture was then tested for overlap shear (OLS) according to the Overlap Shear Test Method described above. Overlap shear test results are summarized in Table 5 for the various formulations tested. The mixture was tested for gel point according to the Gel Point Test Method described above. Gel point calculations are summarized in Tables 3 and 4. Table 4 specifically compares the impact of catalyst concentration on time to reach a gel point.















TABLE 2









ALCOHOL
DIOL

BiND

















PREPARATIVE

Amount,
Relative

Amount,
Relative
DN3400,
CATALYST,
URETDIONE


EXAMPLE
Type
g
Equiv.
Type
g
Equiv.
g
g
FUNCTIONALITY



















PEX-1A
2-butanol
0.90
0.63
2,2-dimethyl-1,3-
0.37
0.37
3.72
0.01
1.74






propanediol


PEX-1B
2-ethyl-
4.00
1.00
NA
NA
0
5.95
0.02
0.94



hexanol


PEX-1C
2-butanol
22.4
0.64
THF1000
86.0
0.36
91.4
1.00
1.74


















TABLE 3









GEL TIME












OLIGOMER
THIOL
CATALYST
(hr = hours;
















Amount,

Amount,

Amount,
min = minutes;


EXAMPLE
Type
g
Type
g
Type
g
sec = seconds)


















EX-2
PEX-1A
3.00
PETMP
0.582
KOtBu
0.043
>2
hr


EX-3
PEX-1A
3.00
PETMP
0.582
KOH
0.021
>2
hr














EX-4
PEX-1A
3.00
PETMP
0.582
TBA Acetate
0.115
instantaneous















EX-5
PEX-1A
3.00
PETMP
0.582
TMA OH (25% aq)
0.140
~4-6
min


EX-6
PEX-1A
3.00
PETMP
0.582
potassium acetate
0.037
25
min







(predissolved in thiol)


EX-7
PEX-1A
3.00
PETMP
0.582
lithium hydroxide
0.009
18
min







(predissolved in thiol)


EX-8
PEX-1A
3.00
PETMP
0.582
potassium carbonate
0.053
10
min







(predissolved in thiol)


EX-9
PEX-1A
3.00
PETMP
0.582
tetramethylammonium
0.069
25
sec







hydroxide pentahydrate







(predissolved in thiol)


EX-10
PEX-1A
3.00
PETMP
0.582
NaOH
0.015
>1
hr







(predissolved in thiol)














EX-11
PEX-1A
3.00
PETMP
0.582
cesium carbonate
0.124
1 min 30 sec







(predissolved in thiol)


EX-12
PEX-1A
3.00
PETMP
0.582
cesium acetate
0.073
3 min 30 sec







(predissolved in thiol)


EX-13
PEX-1A
3.00
PETMP
0.582
sodium acetate trihydrate
0.052
>1 hr < 72 hr







(predissolved in thiol)















EX-14
PEX-1A
3.00
PETMP
0.582
KOtBu
0.043
45
min







(predissolved in thiol)


EX-15
PEX-1A
3.00
PETMP
0.582
KOH
0.021
<30
sec







(predissolved in thiol)


CEX-A
PEX-1A
3.00
PETMP
0.582
no catalyst
0.000
>24
hr


CEX-B
PEX-1A
3.00
PETMP
0.582
TsOH*H2O
0.072
>5
days


CEX-C
PEX-1A
3.00
PETMP
0.582
BiND
0.052
>24
hr


CEX-D
PEX-1A
3.00
PETMP
0.582
ZnND
0.052
>24
hr


CEX-E
PEX-1A
3.00
PETMP
0.582
DBTL
0.25
>24
hr


CEX-F
PEX-1A
3.00
PETMP
0.582
zirconium 2,4-
0.097
>24
hr







pentadionate


CEX-G
PEX-1A
3.00
PETMP
0.582
1,5-diazabycyclo-
0.055
<30
sec







[4.3.0]non-5-ene


CEX-H
PEX-1A
3.00
PETMP
0.582
7-methyl-1,5,7-
0.055
< 30
sec







triazabicyclo[4.4.0]dec-







5ene


CEX-I
PEX-1A
3.00
PETMP
0.582
1,5,7-triazabicyclo-
0.055
< 30
sec







(4.4.0)dec-5-ene







(predissolved in thiol)














CEX-J
PEX-1A
3.00
PETMP
0.582
DBU
0.058
instantaneous















CEX-K
PEX-1A
3.00
PETMP
0.582
PDBU
0.072
<30
sec


















TABLE 4









GEL TIME












OLIGOMER
THIOL
CATALYST
(hr = hours;
















Amount,

Amount,

Amount,
min = minutes;


EXAMPLE
Type
g
Type
g
Type
g
sec = seconds)


















EX-16
PEX-1A
3.00
PETMP
0.582
TMA OH (25% aq)
0.140
4-6
min














EX-17
PEX-1A
3.00
PETMP
0.582
TMA OH (25% aq)
0.279
1 min 22 sec


EX-18
PEX-1A
3.00
PETMP
0.582
cesium carbonate
0.124
1 min 30 sec







(dissolved in the PETMP)















EX-19
PEX-1A
3.00
PETMP
0.582
cesium carbonate
0.249
46
sec







(dissolved in the PETMP)














EX-20
PEX-1A
3.00
PETMP
0.582
cesium acetate (dissolved
0.073
3 min 30 sec







in the PETMP)


EX-21
PEX-1A
3.00
PETMP
0.582
cesium acetate (dissolved
0.146
2 min 3 sec







in the PETMP)





















TABLE 5











OVERLAP SHEAR




URETDIONE

ON ALUMINUM,



RESIN
CURING AGENT
psi (MPa)


















Amount,

Amount,

Amount,

Std.



EXAMPLE
Oligomer
g
Thiol
g
Catalyst
g
Average
Deviation
COMMENTS



















EX-22
PEX-1A
3.0
PETMP
0.582
TMA OH
0.140
32.9
12.5








(25% aq)

(0.23)
(0.09)


EX-23
PEX-1A
3.0
PETMP
0.382
potassium
0.037
92.3
79.6
catalyst predissolved in







acetate

(0.64)
(0.55)
200 mg PETMP


EX-24
PEX-1A
3.0
PETMP
0.382
cesium
0.124
23.05
NA
catalyst predissolved in







carbonate

(0.16)

200 mg PETMP


EX-25
PEX-1A
3.0
PETMP
0.382
cesium
0.073
10.71
NA
catalyst predissolved in







acetate

(0.07)

200 mg PETMP


EX-26
PEX-1C
3.0
PETMP
.36
potassium
0.02
57.2
14.8
catalyst predissolved in







acetate

(0.39)
(0.10)
50 mg DMDO


CEX-L
PEX-1B
3.0
PETMP
0.467
potassium
0.03
Did not
NA
catalyst predissolved in







acetate

form

50 mg DMDO









adequate









bond for









OLS









testing


EX-27
PEX-1A
3.0
TMPTMP
0.60
potassium
0.06
46.5
18.0
catalyst predissolved in







acetate

(0.32)
(0.12)
100 mg PETMP


EX-28
PEX-1C
3.0
TMPTMP
0.60
potassium
0.06
25.3
 6.0
catalyst predissolved in







acetate

(0.17)
(0.04)
100 mg PETMP


CEX-M
PEX-1A
5.00
PETMP
0.97
DBU
0.10
NA
NA
cured before OLS











could be made


CEX-N
PEX-1A
5.00
PETMP
0.97
DBU
0.04
NA
NA
cured before OLS











could be made


CEX-O
PEX-1A
3
PETMP
0.58
no catalyst
0
NA
NA
did not form an











adequate bond for OLS











testing


CEX-P
PEX-1A
3
PETMP
0.58
TsOH*H2O
0.0453
NA
NA
did not form an











adequate bond for OLS











testing


CEX-Q
PEX-1A
3
PETMP
0.58
BiND
0.052
NA
NA
did not form an











adequate bond for OLS











testing


CEX-R
PEX-1A
3
PETMP
0.58
ZnND
0.052
NA
NA
did not form an











adequate bond for OLS











testing


CEX-S
PEX-1A
3
PETMP
0.58
DBTL
0.25
NA
NA
did not form an











adequate bond for OLS











testing


CEX-T
PEX-1A
3
PETMP
0.58
zirconium
0.097
NA
NA
did not form an







2,4-



adequate bond for OLS







pentadionate



testing









All cited references, patents, and patent applications in the above application for letters patent are herein incorporated by reference in their entirety in a consistent manner. In the event of inconsistencies or contradictions between portions of the incorporated references and this application, the information in the preceding description shall control. The preceding description, given in order to enable one of ordinary skill in the art to practice the claimed disclosure, is not to be construed as limiting the scope of the disclosure, which is defined by the claims and all equivalents thereto.

Claims
  • 1-26. (canceled)
  • 27. A two-part curable composition comprising: a Part A composition comprising at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01;a Part B composition comprising at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; andwherein at least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula M+xZb−y wherein M+ is a cation having a single positive charge;Zb− is an oxide anion having a negative charge b−, wherein b is 1 or 2; andx and y are positive integers, wherein x equals y times b.
  • 28. The two-part curable composition of claim 27, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.
  • 29. The two-part curable composition of claim 27, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.
  • 30. The two-part curable composition of claim 27, wherein the at least one polythiol has an average sulfhydryl group functionality of at least 2.5.
  • 31. The two-part curable composition of claim 27, wherein the Part A composition and the Part B composition are flowable at 20° C.
  • 32. A cured composition comprising an at least partially cured reaction product of a curable composition comprising: at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01;at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; andat least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula M+xZb−y wherein M+ is a cation having a single positive charge;Zb− is an oxide anion having a negative charge b−, wherein b is 1 or 2; andx and y are positive integers, wherein x equals y times b.
  • 33. The cured composition of claim 32, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.
  • 34. The cured composition of claim 32, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.
  • 35. A method of bonding first and second substrates, the method comprising: i) providing a curable composition comprising: at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; andat least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula M+xZb−y wherein M+ is a cation having a single positive charge;Zb− is an oxide anion having a negative charge b−, wherein b is 1 or 2; and x and y are positive integers, wherein x equals y times b;ii) contacting the curable composition with the first and second substrates; andiii) at least partially curing the curable composition.
  • 36. The method of claim 35, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.
  • 37. The method of claim 35, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.
  • 38. The method of claim 35, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01.
  • 39. An assembly comprising a composition sandwiched between first and second substrates, wherein the composition comprises a reaction product of a curable composition comprising: at least one polyuretdione, the at least one polyuretdione having an average uretdione ring functionality of at least 1.2;at least one polythiol, the at least one polythiol having an average sulfhydryl group functionality of at least 1.2; andat least one of the Part A composition and the Part B composition further comprises at least one accelerator for ring-opening addition of the at least one polythiol to the at least one polyuretdione, and wherein the at least one accelerator comprises a basic salt having the formula M+xZb−y wherein M+ is a cation having a single positive charge;Zb− is an oxide anion having a negative charge b−, wherein b is 1 or 2; andx and y are positive integers, wherein x equals y times b.
  • 40. The assembly of claim 39, wherein M is selected from lithium, sodium, potassium, cesium, and quaternary ammonium.
  • 41. The assembly of claim 39, wherein Z is selected from the group consisting of hydroxide, carbonate, and carboxylates.
  • 42. The assembly of claim 39, wherein the at least one polyuretdione has an average isocyanate functionality of less than 0.01.
  • 43. The assembly of claim 39, wherein the at least one polythiol has an average sulfhydryl group functionality of at least 2.5.
  • 44. The assembly of claim 39, wherein the curable composition is flowable at 20° C. before curing.
PCT Information
Filing Document Filing Date Country Kind
PCT/IB2019/051808 3/6/2019 WO 00
Provisional Applications (1)
Number Date Country
62643891 Mar 2018 US